Alemtuzumab Intravenous and Claravis
Determining the interaction of Alemtuzumab Intravenous and Claravis and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: isotretinoin
Brand name: Absorica, Amnesteem, Claravis, Myorisan, Sotret, Zenatane, Accutane
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Clarifoam EF
- Alemtuzumab Intravenous-Clarinex
- Alemtuzumab Intravenous-Clarinex (Desloratadine Syrup)
- Alemtuzumab Intravenous-Clarinex (Desloratadine Tablets)
- Alemtuzumab Intravenous-Clarinex Reditabs
- Alemtuzumab Intravenous-Clarinex-D
- Claravis-Alenaze-D
- Claravis-Alendronate
- Claravis-Alendronate and cholecalciferol
- Claravis-Alendronate Effervescent Tablets
- Claravis-Alendronate Oral Solution
- Claravis-Alendronate Sodium